Aytu BioPharma (AYTU) Stock Insights

AYTU price $1.97 +0.07 +3.68%

Ticker
AYTU
Price
$1.97
Change
+0.07 +3.68%
Market cap ?
$21.41M
P/E ?
-1.43
Forward P/E ?
7.30
Dividend yield ?
0.00%
Beta ?
0.27
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stocklytics score
36
Value
76
Quality
28
Growth
3

Stocklytics score rationale: value 76, quality 28, growth 3.

Financials

2017201820192020202120222023202420252026
322159036600007320357276320006563200096669000107399000651830006638200057570000

Aytu BioPharma, Inc. is a specialized pharmaceutical firm dedicated to advancing and marketing innovative therapeutic drugs and consumer health products, serving both domestic U.S. and international markets. Its commercialized portfolio includes several treatments for Attention Deficit Hyperactivity Disorder (ADHD): Adzenys XR-ODT, prescribed for patients aged 6 and up; Cotempla XR-ODT, tailored for individuals…

Fair value

AYTU fair value $24.48. Price $1.97. Price is 92% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 9.76M. Growth 17.97%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 10.87M. Net debt -8.20M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare AYTU

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.26—13.27M
2026-09-22-0.05-0.2916.11M12.28M
2026-05-13-0.53-0.3112.41M12.05M
2026-02-03-1.05-0.2615.20M12.17M
2025-11-13-0.08-0.0613.89M12.60M
2025-09-23-2.92-0.0215.13M17.92M
2025-05-140.20-0.1718.45M13.74M
2025-02-12-0.28-0.2816.22M15.55M
2024-11-13-0.20-0.3416.57M13.77M
2024-09-26-0.82-0.4517.98M18.30M
2024-05-15-0.52-0.6417.99M17.35M
2024-02-14-0.04-0.2522.93M21.75M
2023-11-14-1.48-0.0422.10M27.73M
2023-09-27-0.59-0.9530.73M27.69M
2023-05-11-1.93-0.6322.70M28.00M
2023-02-21-1.310.2026.28M29.50M
2022-11-14-1.20-3.6027.66M24.30M
2022-09-27-5.00-4.8027.45M25.70M
2022-05-16-5.40-8.2024.20M24.20M
2022-02-14-8.80-8.8023.12M23.10M
2021-11-15-13.40-3.2021.90M18.25M
2021-09-27-16.20-0.0223.48M24.70M
2021-05-17-3.40-7.2013.48M14.68M
2021-02-11-9.40-10.0015.15M12.25M
2020-11-12-8.00-11.0013.52M16.22M
2020-10-06-4.00-7.0014.86M18.25M
2020-05-14-30.00-44.008.16M11.96M
2020-02-13-0.62-0.683.18M76.21M
2019-11-14-0.64-0.551.44M1.26M
2019-09-26-2.60-0.821.72M1.77M
2019-05-14-1.00-1.162.38M2.76M
2019-02-07-1.28-0.791.80M1.54M
2018-11-07-3.92-2.901.43M1.06M
2018-09-060.61-0.01925.00K1.06M
2018-05-14-20.00-0.01607.00K7.53M
2018-02-08-35.60-71.201.05M2.10M
2017-11-09-70.40-304.001.08M4.66M
2017-08-31-166.40-344.00835.89K1.74M
2017-05-11-384.00-296.00894.00K679.88K
2017-02-09-440.00-416.00794.00K790.00K

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-28Disbrow Joshua R.Buy30.00K——
2026-07-28PYSZCZYMUKA GREGBuy20.00K——
2026-07-28Disbrow JarrettBuy15.00K——
2026-07-28Selhorn Ryan JBuy25.00K——
2026-07-28LIU VIVIAN HBuy10.00K——
2026-07-28JAIN ABHINAVBuy10.00K——
2026-07-28DOCKERY CARLBuy10.00K——
2026-07-28Donofrio John Jr.Buy10.00K——
2025-10-03PYSZCZYMUKA GREGBuy12.50K——
2025-10-03Disbrow JarrettBuy12.50K——
2025-10-03Disbrow JarrettBuy19.61K——
2025-10-03Selhorn Ryan JBuy17.50K——
2025-10-03Selhorn Ryan JBuy16.24K——
2025-10-03Disbrow Joshua R.Buy22.50K——
2025-10-03Disbrow Joshua R.Buy31.45K——
2025-10-03LIU VIVIAN HBuy10.00K——
2025-10-03JAIN ABHINAVBuy10.00K——
2025-10-03DOCKERY CARLBuy10.00K——
2025-10-03Donofrio John Jr.Buy10.00K——
2025-06-30DOCKERY CARLOther0——
2025-06-09Disbrow JarrettBuy16.67K$1.5025.00K
2025-06-09Disbrow Joshua R.Buy66.67K$1.50100.00K
2025-06-06Nantahala Capital Management, LLCBuy4.00M$0.00400
2025-03-31PYSZCZYMUKA GREGBuy209——
2025-03-31PYSZCZYMUKA GREGSell209——
2025-02-28Disbrow Joshua R.Buy15.00K$1.3019.50K
2025-02-05Selhorn Ryan JBuy105——
2025-02-05Selhorn Ryan JSell105——
2024-12-31PYSZCZYMUKA GREGBuy208——
2024-12-31PYSZCZYMUKA GREGSell208——
2024-11-11Selhorn Ryan JBuy14.00K——
2024-11-11Selhorn Ryan JOther0——
2024-11-11Selhorn Ryan JOther5.00K$1.738.65K
2024-11-11Selhorn Ryan JOther5.00K$1.849.20K
2024-11-11Selhorn Ryan JOther5.79K$4.0023.16K
2024-11-11Selhorn Ryan JOther105——
2024-11-06DOCKERY CARLBuy1.50K——
2024-11-06Donofrio John Jr.Buy1.50K——
2024-11-06JAIN ABHINAVBuy1.50K——
2024-11-06Disbrow Joshua R.Buy38.00K$1.8469.92K
2024-11-06Disbrow JarrettBuy7.00K$1.8412.88K
2024-11-06LIU VIVIAN HBuy1.50K——
2024-11-06PYSZCZYMUKA GREGBuy7.00K$1.8412.88K
2024-09-30PYSZCZYMUKA GREGBuy209——
2024-09-30PYSZCZYMUKA GREGSell209——
2024-06-30PYSZCZYMUKA GREGBuy208——
2024-06-30PYSZCZYMUKA GREGSell208——
2024-06-14Nantahala Capital Management, LLCBuy815.22K$0.0082
2024-06-14Nantahala Capital Management, LLCSell815.22K$1.591.30M
2024-03-31PYSZCZYMUKA GREGBuy208——
2024-03-31PYSZCZYMUKA GREGSell208——
2023-12-31PYSZCZYMUKA GREGBuy209——
2023-12-31PYSZCZYMUKA GREGSell209——
2023-09-30PYSZCZYMUKA GREGBuy208——
2023-09-30PYSZCZYMUKA GREGSell208——
2023-08-16JAIN ABHINAVBuy6.50K——
2023-08-11LIU VIVIAN HBuy1.50K——
2023-08-11Disbrow JarrettBuy7.00K$1.7312.11K
2023-08-11JAIN ABHINAVBuy1.50K——
2023-08-11LIU VIVIAN HBuy1.50K——
2023-08-11Donofrio John Jr.Buy1.50K——
2023-08-11DOCKERY CARLBuy1.50K——
2023-08-11Disbrow Joshua R.Buy35.00K$1.7360.55K
2023-08-11BROOKE CHRISTOPHERBuy7.00K$1.7312.11K
2023-08-11Oki Mark KBuy13.00K$1.7322.49K
2023-08-11PYSZCZYMUKA GREGBuy7.00K$1.7312.11K
2023-06-30PYSZCZYMUKA GREGBuy208——
2023-06-30PYSZCZYMUKA GREGSell208——
2023-06-16PYSZCZYMUKA GREGBuy12.00K$1.8722.43K
2023-06-14Disbrow Joshua R.Buy14.00K$1.8626.08K
2023-06-13Nantahala Capital Management, LLCOther0——
2023-06-13Nantahala Capital Management, LLCOther815.22K——
2023-06-13Nantahala Capital Management, LLCOther815.22K——
2023-06-13JAIN ABHINAVOther0——
2023-04-25PYSZCZYMUKA GREGBuy833——
2023-04-25PYSZCZYMUKA GREGSell833——
2023-02-08LIU VIVIAN HBuy6.50K——
2022-12-21Donofrio John Jr.Sell187.80K——
2022-12-21Cantrell GarySell40.00K——
2022-12-21DOCKERY CARLSell40.00K——
2022-12-20Disbrow Joshua R.Sell80.00K——
2022-12-19Disbrow Joshua R.Buy112.37K$0.2225.05K
2022-12-19PYSZCZYMUKA GREGBuy100.00K$0.2424.48K
2022-11-18Oki Mark KBuy90.00K$0.2320.70K
2022-11-18Disbrow Joshua R.Buy222.00K$0.2452.61K
2022-11-18Disbrow Joshua R.Buy222.00K$0.2452.61K
2022-11-18Oki Mark KBuy90.00K$0.2320.70K
2022-11-15PYSZCZYMUKA GREGSell50.00K——
2022-11-15PYSZCZYMUKA GREGSell0——
2022-11-15Disbrow JarrettSell15$3,280.0049.20K
2022-11-15Disbrow JarrettSell0——
2022-11-15BROOKE CHRISTOPHERSell135.00K$0.2027.00K
2022-11-15BROOKE CHRISTOPHERSell0——
2022-07-01LIU VIVIAN HBuy6.50K——
2022-07-01LIU VIVIAN HOther0——
2022-01-17Oki Mark KBuy100.00K——
2022-01-17Oki Mark KOther0——
2021-04-16DOCKERY CARLBuy187.80K——
2021-04-16MACALUSO MICHAELBuy187.80K——
2021-04-16Donofrio John Jr.Buy187.80K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 36, holders +1 vs prior quarter. Ownership 36.49%.

HolderSharesChangeChange %Value
NANTAHALA CAPITAL MANAGEMENT, LLC1.09M00.00%2.34M
STONEPINE CAPITAL MANAGEMENT, LLC912.92K120.63K+15.23%1.96M
AWM INVESTMENT COMPANY, INC.619.57K00.00%1.33M
VANGUARD CAPITAL MANAGEMENT LLC261.15K00.00%561.46K
CROWN ADVISORS MANAGEMENT, INC.200.00K55.00K+37.93%430.00K
DIADEMA PARTNERS LP148.55K-204.53K-57.93%319.37K
TWO SIGMA INVESTMENTS, LP105.33K-16.65K-13.65%226.45K
RENAISSANCE TECHNOLOGIES LLC104.82K11.10K+11.84%225.37K
GEODE CAPITAL MANAGEMENT, LLC93.65K1.01K+1.09%201.37K
CITADEL ADVISORS LLC49.41K12.57K+34.13%106.24K
VANGUARD FIDUCIARY TRUST CO47.05K00.00%101.15K
DIMENSIONAL FUND ADVISORS LP45.33K1.74K+3.99%97.45K
PERSISTENT ASSET PARTNERS LTD37.98K-54.91K-59.11%81.67K
NORTHERN TRUST CORP27.93K8.76K+45.68%60.04K
BELLEVUE ASSET MANAGEMENT, LLC25.01K00.00%53.78K
BLACKROCK, INC.22.79K00.00%49.01K
XTX TOPCO LTD21.42K-166-0.77%46.04K
DAYTONA STREET CAPITAL LLC10.00K00.00%22.35K
ACADIAN ASSET MANAGEMENT LLC10.24K00.00%22.00K
UBS GROUP AG2.38K714+42.93%5.11K
TOWER RESEARCH CAPITAL LLC (TRC)2.23K668+42.71%4.80K
ROYAL BANK OF CANADA378378New1.00K
OSAIC HOLDINGS, INC.46200.00%991
JPMORGAN CHASE & CO15400.00%337
WELLS FARGO & COMPANY/MN12700.00%273

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Aytu BioPharma (AYTU) Stock Insights

AYTU$1.97+0.07 +3.68%

$21.41M

Market Cap

-1.43

P/E

7.30

Forward P/E

36

Score

Price History